Skip to main content

SUGAMMADEX KABI (Fresenius Kabi Australia Pty Ltd)

Product name
Date registered
Evaluation commenced
Decision date
Approval time
133 (255 working days)
Active ingredients
sugammadex sodium
Registration type
New generic medicine

Reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

Help us improve the Therapeutic Goods Administration site